Clinical / Scientific Presentation and Publication Highlights

European Hematology Association Congress (EHA) 2019 – STRO-001 Poster

European Hematology Association Congress (EHA) 2019 Preliminary results of a Phase 1 dose escalation study of the first-in-class anti-CD74 antibody drug conjugate (ADC), STRO-001, in.. Read More →

European Hematology Association (EHA) 2019 – STRO-001 Abstract

Preliminary Results Of A Phase 1 Dose Escalation Study Of The First-In-Class Anti-CD74 Antibody Drug Conjugate (ADC), STRO-001, In Patients With Advanced B-Cell Malignancies. Abstract.. Read More →

Sutro Biopharma Announces Presentation at the 2019 European Hematology Association Congress

SOUTH SAN FRANCISCO, Calif., May 16, 2019 – Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that the company will present at the upcoming European Hematology.. Read More →

American Association for Cancer Research (AACR) 2019 – STRO-002 Abstract 2897

American Association for Cancer Research (AACR) 2019 Abstract 3897: Stability and safety evaluation of STRO-002, a site-specific anti-folate receptor alpha antibody-drug conjugate for the potential.. Read More →

American Association for Cancer Research (AACR) 2019 – STRO-002 Poster

American Association for Cancer Research (AACR) 2019 A Phase 1 Open-Label, Safety, Pharmacokinetic, And Preliminary Efficacy Study Of STRO-002, An Anti-Folate Alpha (FolRα) Antibody Drug.. Read More →

American Association for Cancer Research (AACR) 2019 – STRO-001 Poster

American Association for Cancer Research (AACR) 2019 A Phase 1 Open-Label, Safety, Pharmacokinetic, And Preliminary Efficacy Study Of STRO-001, An Anti-CD74 Antibody Drug Conjugate, In.. Read More →

Sutro Biopharma to Present at the 18th Annual Needham Healthcare Conference

SOUTH SAN FRANCISCO, Calif., April 4, 2019 – Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that Bill Newell, Chief Executive Officer, will present at the.. Read More →

Non-Confidential Corporate Presentation – JPM 2019

Non-Confi Presentation 1-19.. Read More →

12th Biennial Ovarian Cancer Research Symposium – STRO-002 Abstract

Objectives: Folate receptor alpha (FolRa) is a cell-surface glycoprotein, highly expressed in ovarian and endometrial adenocarcinoma, and is thus a promising target for cancer therapy.. Read More →

12th Biennial Ovarian Cancer Research Symposium – STRO-002 Poster

Preclinical Activity and Safety of STRO-002, a Novel ADC Targeting Folate Receptor Alpha for Ovarian Cancer STRO-002 Rivkin Poster 08092018.. Read More →

American Society of Clinical Oncology (ASCO) 2018 – Poster

 A PHASE 1 OPEN-LABEL, SAFETY, PHARMACOKINETIC, AND PRELIMINARY EFFICACY STUDY OF STRO-001, AN ANTI-CD74 ANTIBODY DRUG CONJUGATE, IN PATIENTS WITH ADVANCED B-CELL MALIGNANCIES, NCT03424603 2018.. Read More →

American Association for Cancer Research (AACR) 2018 – STRO-002 Poster

American Association for Cancer Research (AACR) 2018 Discovery and Activity of STRO-002, a Novel ADC Targeting Folate Receptor Alpha for Ovarian and Endometrial Cancer STRO-002 AACR.. Read More →

American Association for Cancer Research (AACR) 2018 – STRO-002 Abstract

Generation and Activity of STRO-002, a novel ADC targeting Folate Receptor Alpha for Ovarian Cancer   Folate receptor alpha (FolRa) is a glycosylphosphatidylinositol linked cell-surface.. Read More →

Society for Gynecologic Oncology (SGO) 2018 – STRO-002 Abstract

Preclinical Activity and Safety of STRO-002, a novel ADC targeting Folate Receptor Alpha for Ovarian Cancer   Objectives: Folate receptor alpha (FolRa) is a cell-surface glycoprotein,.. Read More →

STRO-001 – Publication Highlights

Pan Pacific Lymphoma, 2018 HIGH FREQUENCY OF CD74 EXPRESSION IN B-CELL NON-HODGKIN’S LYMPHOMA (NHL) AND TARGETING WITH STRO-001, A NOVEL ANTI-CD74 ANTIBODY DRUG CONJUGATE (ADC).. Read More →

Science and Platform Publication Highlights

Biotechnol Bioeng. 2011 Jul;108(7):1570-8. doi: 10.1002/bit.23103. Epub 2011 Mar 31. Microscale to manufacturing scale-up of cell-free cytokine production–a new approach for shortening protein production development.. Read More →

American Society of Hematology (ASH) 2017 – Oral Presentation

High Frequency of CD74 Expression in B-cell Non-Hodgkin’s Lymphoma (NHL) and Targeting with STRO-001, a Novel Anti-CD74 Antibody Drug Conjugate (ADC) with Potent In Vitro.. Read More →

American Association for Cancer Research (AACR) 2017 – Poster

Characterization and pre-clinical development of STRO-001, a novel CD74-targeting antibody-drug conjugate (ADC) for the treatment of B-cell malignancies  2017 combined MM and NHL AACR FINAL.. Read More →

American Society of Hematology (ASH) 2016 – NHL Oral Presentation

Targeting CD74 with Novel Antibody Drug Conjugates (ADCs) for the Treatment of B-Cell Non-Hodgkin’s Lymphoma Arturo Molina, MD, MS Sutro Biopharma ASH Annual Meeting 2016.. Read More →

American Society of Hematology (ASH) 2016 – Poster

Discovery and preclinical development of novel CD74-targeting antibody-drug conjugates (ADCs) with significant activity in multiple myeloma (MM) cell lines and xenograft models 2016 DEC ASH.. Read More →

Production of bispecific antibodies in “knobs-into- holes” using a cell-free expression system

Yiren Xu, John Lee, Cuong Tran, Tyler H Heibeck, Willie D Wang, Junhao Yang, Ryan L Stafford, Alexander R Steiner, Aaron K Sato, Trevor J Hallam,.. Read More →

Methods to Make Homogenous Antibody Drug Conjugates

Toni Kline, Alexander R. Steiner, Kalyani Penta, Aaron K. Sato, Trevor J. Hallam, Gang Yin,  Methods to Make Homogenous Antibody Drug Conjugates Pharmaceutical Research December 2014,.. Read More →

A General Sequence Processing and Analysis Program for Protein Engineering

Ryan L. Stafford,* Erik S. Zimmerman, Trevor J. Hallam, and Aaron K. Sato, A General Sequence Processing and Analysis Program for Protein Engineering, dx.doi.org/10.1021/ci500362s | J... Read More →

World ADC Summit 2013 – Dual-Warhead Antibody Drug Conjugate

SAN FRANCISCO, Oct. 15, 2013 – Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics utilizing Sutro’s cell-free protein synthesis technology, presented today.. Read More →

Producing Homogeneous ADCs with Combination Warheads

Hallam, Trevor, Producing Homogeneous ADCs with Combination Warheads Presented at the 4th World ADC Summit, San Francisco (PDF) Read More.. Read More →

Cell-free translation of peptides and proteins: from high throughput screening to clinical production

Christopher J Murray, and Ramesh Baliga, Cell-free translation of peptides and proteins: from high throughput screening to clinical production,  Current Opinion in Chemical Biology 2013,.. Read More →

Rapid Design and Manufacture of Single Species, Site-Specific ADCs using Cell-Free Synthesis with nnAAs

Hallam, Trevor, Rapid Design and Manufacture of Single Species, Site-Specific ADCs using Cell-Free Synthesis with nnAAs. Presented at the 3rd World ADC Summit, San Francisco.. Read More →

Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system

Gang Yin, Eudean D. Garces, Junhao Yang, Juan Zhang, Cuong Tran, Alexander R. Steiner, Christine Roos, Sunil Bajad, Susan Hudak, Kalyani Penta, James Zawada, Sonia.. Read More →

Preparation and Testing of E. coli S30 In Vitro Transcription Translation Extracts

James F. Zawada, Preparation and Testing of E. coli S30 In Vitro Transcription Translation Extracts Ribosome Display and Related Technologies Methods in Molecular Biology Volume.. Read More →

Microscale to Manufacturing Scale-up of Cell-Free Cytokine Production: A New Approach for Shortening Protein Production Development Timelines

James F. Zawada, Gang Yin, Alexander R. Steiner, Junhao Yang, Alpana Naresh, Sushmita M. Roy, Daniel S. Gold, Henry G. Heinsohn, Christopher J. Murray, Microscale.. Read More →

A robust, rapid and scalable cell free expression system for the production and engineering of Fab antibodies

Garces, Eudean et. al., A robust, rapid and scalable cell free expression system for the production and engineering of Fab antibodies. Presented at the IBC.. Read More →

Translation Fidelity Rate Determination in a Cell-Free Protein Synthesis System using LC-MS

Heibeck, Tyler H., et. al., Translation Fidelity Rate Determination in a Cell-Free Protein Synthesis System using LC-MS. 58th American Society for Mass Spectrometry Conference on.. Read More →

Towards scalable cell-free synthesis of non-native amino acid containing proteins

Rozzelle, James E., et.al., Towards scalable cell-free synthesis of non-native amino acid containing proteins. Presented at American Chemical Society Spring Meeting, San Francisco, CA. Read.. Read More →